TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32270635

Group type: EXPERIMENTAL
Intervention: Stiletto needle combined with massotherapy
Number of subjects: 156

Group type: COMPARATOR
Intervention: Articular injection of sodium hyaluronate
Number of subjects: 156
Study: 35715871

Group type: EXPERIMENTAL
Intervention: Agitated syringe (siliconized or silicone oil-free)
Number of subjects: 41

Group type: COMPARATOR
Intervention: No agitation (control group)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Siliconized syringe
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Silicone oil-free syringe
Number of subjects: 41
Study: 32635765

Group type: EXPERIMENTAL
Intervention: Friendship with a migraineur
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: Social network clustering of migraineurs
Number of subjects: 610
Study: 35122096

Group type: EXPERIMENTAL
Intervention: 6-month multimodal intervention based on diet and a physical activity program
Number of subjects: 305

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 305
Study: 32860791

Group type: EXPERIMENTAL
Intervention: aFMT (autologous fecal microbiota transplantation)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 34870388

Group type: EXPERIMENTAL
Intervention: HIIT-low volume (n = 29), 6 intervals of 1-minute high-intensity phases at 90% VO2peak
Number of subjects: 60

Group type: COMPARATOR
Intervention: MICT (n = 31), trained at 60% VO2peak for 30 minutes
Number of subjects: 60
Study: 35590011

Group type: EXPERIMENTAL
Intervention: iRARC with ileal conduit
Number of subjects: 50

Group type: COMPARATOR
Intervention: ORC with ileal conduit
Number of subjects: 50
Study: 33449816

Group type: EXPERIMENTAL
Intervention: CNI/MTX plus abatacept
Number of subjects: 185

Group type: COMPARATOR
Intervention: CNI/MTX plus placebo
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: CNI/MTX plus abatacept (7/8 cohort)
Number of subjects: 185

Group type: COMPARATOR
Intervention: CNI/MTX (nonrandomized matched cohort)
Number of subjects: 185
Study: 34727277

Group type: EXPERIMENTAL
Intervention: Pre-treatment group (400 mg celecoxib at 4 h before THA, 200 mg at 4 h after THA, then 200 mg every 12 h until 72 h post-operation)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Pre-treatment group
Number of subjects: 192

Group type: COMPARATOR
Intervention: Post-treatment group
Number of subjects: 192
Study: 32436913

Group type: EXPERIMENTAL
Intervention: Longer etching time, total-etch adhesive system, and EDTA pre-treatment of sclerotic dentin in cervical wedge-shaped defects
Number of subjects: 0
Study: 33217117

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg bid)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 36088479

Group type: EXPERIMENTAL
Intervention: Ripasudil
Number of subjects: 16

Group type: COMPARATOR
Intervention: Latanoprost
Number of subjects: 16
Study: 33595848

Group type: EXPERIMENTAL
Intervention: Rubber dam (group 1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Retraction cord with copy abutment (group 2)
Number of subjects: 20
Study: 32928123

Group type: EXPERIMENTAL
Intervention: Wheat bran arabinoxylan oligosaccharides (AXOS) supplementation
Number of subjects: 21

Group type: COMPARATOR
Intervention: Maltodextrin supplementation
Number of subjects: 21
Study: 33097481

Group type: EXPERIMENTAL
Intervention: Early mobilisation programme
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no early mobilisation programme)
Number of subjects: 80
Study: 34163144

Group type: EXPERIMENTAL
Intervention: Digital evidence-based patient decision aid (EbPDA) for hypertension
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group (searching for information without support)
Number of subjects: 124
Study: 36280012

Group type: EXPERIMENTAL
Intervention: PMBE (1322 mg PMBE)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo (0 mg PMBE)
Number of subjects: 62
Study: 36146919

Group type: EXPERIMENTAL
Intervention: Double portion of food (e.g., double portion of banana, carrot, loaf cake, salami)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Double portion of food
Number of subjects: 89

Group type: COMPARATOR
Intervention: Reference portion of food (e.g., half a banana, half a large peeled carrot, a slice of loaf cake, half a salami stick)
Number of subjects: 89
Study: 32822362

Group type: COMPARATOR
Intervention: Seasonal malaria chemoprevention (SMC) plus placebo
Number of subjects: 10000

Group type: EXPERIMENTAL
Intervention: SMC within the past 28 days
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Children who missed the SMC course preceding the survey contact
Number of subjects: 10000

Group type: EXPERIMENTAL
Intervention: SP + AQ regimen in children with asymptomatic malaria
Number of subjects: 10000
Study: 35313852

Group type: EXPERIMENTAL
Intervention: Low Healthy Eating Index (HEI)
Number of subjects: 1738

Group type: EXPERIMENTAL
Intervention: Pre-pregnancy Body Mass Index (BMI) and HEI interaction
Number of subjects: 1738

Group type: EXPERIMENTAL
Intervention: Energy % from protein and intake of average portions of vegetables and cereals
Number of subjects: 1738

Group type: COMPARATOR
Intervention: Low Physical Activity (PA) levels
Number of subjects: 1738

Group type: COMPARATOR
Intervention: Antenatal anxiety/distress
Number of subjects: 1738

Group type: COMPARATOR
Intervention: Different types of PA
Number of subjects: 1738
Study: 33938674

Group type: EXPERIMENTAL
Intervention: US guided SGB with 5 mL of 0.5% bupivacaine and multimodal systemic analgesia (Group A)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Multimodal systemic analgesia only (Group B)
Number of subjects: 80
Study: 33239306

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT) in the ESCAPE-NA1 trial
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT) in the DAWN trial
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT) in the DEFUSE-3 trial
Number of subjects: 111
Study: 70634317

Group type: EXPERIMENTAL
Intervention: Cell treatment (all groups pooled)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Baseline wound area
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Baseline bacterial counts (>10,000 cfu/gm)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Cell treated group
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Clinically evident wound infection
Number of subjects: 228
Study: 35156955

Group type: EXPERIMENTAL
Intervention: Individual coaching sessions (9 hours over 4-6 months)
Number of subjects: 176

Group type: COMPARATOR
Intervention: General coaching information (fortnightly)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Individual coaching sessions
Number of subjects: 176
Study: 32394496

Group type: EXPERIMENTAL
Intervention: Stress management program
Number of subjects: 49
Study: 33295981

Group type: EXPERIMENTAL
Intervention: Lower PEEP (0-5 cm H2O), n=476
Number of subjects: 980

Group type: COMPARATOR
Intervention: Higher PEEP (8 cm H2O), n=493
Number of subjects: 980

Group type: EXPERIMENTAL
Intervention: Lower PEEP
Number of subjects: 980

Group type: COMPARATOR
Intervention: Higher PEEP
Number of subjects: 980
Study: 36174779

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle interventions (ILI)
Number of subjects: 4640

Group type: COMPARATOR
Intervention: Diabetes support and education (DSE)
Number of subjects: 4640
Study: 34142392

Group type: EXPERIMENTAL
Intervention: Nigella sativa oil extract (500 mg per day for 8 weeks)
Number of subjects: 43
Study: 32938280

Group type: EXPERIMENTAL
Intervention: 48 hours of hypothermia
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 72 hours of hypothermia
Number of subjects: 92

Group type: COMPARATOR
Intervention: Routine treatment
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 92
Study: 35315012

Group type: EXPERIMENTAL
Intervention: Contained collection bag for power morcellation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Open power morcellation
Number of subjects: 20
Study: 34544429

Group type: EXPERIMENTAL
Intervention: Mobile app education + routine care
Number of subjects: 40

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 40
Study: 36127630

Group type: EXPERIMENTAL
Intervention: C-reactive protein point-of-care testing and educational training
Number of subjects: 2039

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 2039
Study: 32956964

Group type: EXPERIMENTAL
Intervention: Learning through Play Plus Thinking Healthy Program (LTP Plus)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 107
Study: 32591464

Group type: EXPERIMENTAL
Intervention: GVAX and ipilimumab (Arm A)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Continuation of FOLFIRINOX (Arm B)
Number of subjects: 82
Study: 36268946

Group type: EXPERIMENTAL
Intervention: Dexamethasone (10 mg) and articaine (68 mg) mixture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 33596969

Group type: EXPERIMENTAL
Intervention: Topical combination of clonidine and pentoxifylline
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 32521472

Group type: EXPERIMENTAL
Intervention: Exercise on a cylinder-shaped tube
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Exercise on a flat surface
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (laid supine on a flat surface)
Number of subjects: 30
Study: 34274494

Group type: COMPARATOR
Intervention: COVID-19 treatments (specific treatments not detailed)
Number of subjects: 0
Study: 35844438

Group type: EXPERIMENTAL
Intervention: ERAS plus integrated traditional Chinese and Western medicine
Number of subjects: 74

Group type: COMPARATOR
Intervention: Routine treatment and care
Number of subjects: 74
Study: 34656029

Group type: EXPERIMENTAL
Intervention: Postoperative immune modulating nutrition (IMN) - Stresson, Nutricia Ltd. for 10-15 days
Number of subjects: 108

Group type: COMPARATOR
Intervention: Isocaloric, isonitrogenous control feed - Nutrison High Protein, Nutricia for 10-15 days
Number of subjects: 108

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 108
Study: 34445964

Group type: EXPERIMENTAL
Intervention: Primary care networks (targeted physicians)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference group (non-targeted physicians)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: General practitioners
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Younger patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Female patients
Number of subjects: 0
Study: 32629117

Group type: EXPERIMENTAL
Intervention: Interferon-gamma release assay (IGRA)
Number of subjects: 336
Study: 35067621

Group type: EXPERIMENTAL
Intervention: Laminar airflow system (LAS)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Conventional airflow system (CAS)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Both groups (LAS and CAS)
Number of subjects: 246
Study: 33548773

Group type: EXPERIMENTAL
Intervention: Guideline development process
Number of subjects: 19

Group type: COMPARATOR
Intervention: High-quality randomized controlled trials
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Qualitative research, real-world data, clinical experience, patient testimony
Number of subjects: 19
Study: 32092927

Group type: EXPERIMENTAL
Intervention: Experimental infant formula (EF)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Standard infant formula (SF)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Breastfed (BF)
Number of subjects: 122
Study: 34310541

Group type: EXPERIMENTAL
Intervention: Fire suppression simulation
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 15
Study: 34063454

Group type: COMPARATOR
Intervention: Plyometric training (P)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Plyometric integrated with balance training (BP)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Control group (C)
Number of subjects: 30
Study: 32362548

Group type: EXPERIMENTAL
Intervention: Group 2 - Depth of insertion determined by distance from skin puncture to second intercostal space
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Group 4 - Length of catheter determined by height-based formula
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Group 3 - Depth of insertion determined by distance from skin puncture to third intercostal space
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Group 1 - Length of catheter determined empirically by operator experience
Number of subjects: 120

Group type: COMPARATOR
Intervention: Comparison of all groups
Number of subjects: 120

Group type: COMPARATOR
Intervention: Correlation with demographic data
Number of subjects: 120
Study: 34198387

Group type: EXPERIMENTAL
Intervention: 3D image reconstruction based on improved U-net network
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional thin-slice CT images
Number of subjects: 40
Study: 32239481

Group type: EXPERIMENTAL
Intervention: Code status discussions with patients
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Medical patients
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Surgical patients
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Physicians determining DNR status without patient consultation
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Physicians who defined DNR status without consultation
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Patients recalling code status discussions
Number of subjects: 403
Study: 36194218

Group type: EXPERIMENTAL
Intervention: Cefepime 2 g/enmetazobactam 0.5 g
Number of subjects: 1041

Group type: COMPARATOR
Intervention: Piperacillin 4 g/tazobactam 0.5 g
Number of subjects: 1041
Study: 35460163

Group type: EXPERIMENTAL
Intervention: App-based treatment for urinary incontinence
Number of subjects: 262

Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 262
Study: 32707225

Group type: EXPERIMENTAL
Intervention: aMAP risk score (cut-off value of 50)
Number of subjects: 17374

Group type: EXPERIMENTAL
Intervention: aMAP risk score (cut-off value of 60)
Number of subjects: 17374

Group type: EXPERIMENTAL
Intervention: Cumulative incidences of HCC in low-risk group (cut-off <50)
Number of subjects: 17374

Group type: EXPERIMENTAL
Intervention: Cumulative incidences of HCC in medium-risk group (cut-off 50-60)
Number of subjects: 17374

Group type: EXPERIMENTAL
Intervention: Cumulative incidences of HCC in high-risk group (cut-off >60)
Number of subjects: 17374
Study: 35861106

Group type: EXPERIMENTAL
Intervention: Vision-screening tool used by nurses and other non-eye care health practitioners (NECHP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vision-screening tool (Group 1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comprehensive orthoptic assessment (Group 2)
Number of subjects: 0
Study: 34274500

Group type: EXPERIMENTAL
Intervention: Total Intravenous Anesthesia (TIVA)
Number of subjects: 22755

Group type: COMPARATOR
Intervention: Balanced anesthesia (volatile inhalational and intravenous agents)
Number of subjects: 22755
Study: 35742717

Group type: EXPERIMENTAL
Intervention: EMDR psychotherapy
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive behavioral therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Both therapies
Number of subjects: 30
Study: 32076899

Group type: EXPERIMENTAL
Intervention: Randomized multiresolution scanning (RAMUS) approach
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hierarchical Bayesian model (HBM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inverse gamma (IG) distribution as primary hyperprior
Number of subjects: 0
Study: 32888384

Group type: EXPERIMENTAL
Intervention: Adipose tissue derived‐stromal vascular fraction (AD‐SVF)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Adipose tissue derived‐stromal vascular fraction plus platelet‐rich plasma (AD‐SVF plus PRP)
Number of subjects: 40
Study: 33202068

Group type: EXPERIMENTAL
Intervention: Use of PROMs in RCTs
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Aggregation of domain scores
Number of subjects: 54

Group type: COMPARATOR
Intervention: Exclusion of domains
Number of subjects: 54
Study: 33301496

Group type: EXPERIMENTAL
Intervention: Dietary intake of β-carotene
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Dietary intake of vitamin C
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Dietary intake of carbohydrates
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Dietary intake of total fat/oil
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Dietary intake of saturated fatty acid (SFA)
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Dietary intake of cholesterol
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Dietary intake of iron
Number of subjects: 612
Study: 35356624

Group type: EXPERIMENTAL
Intervention: Uterine Artery Embolization (UAE)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Uterine Artery Ligation (UAL)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both UAL and UAE
Number of subjects: 100
Study: 34302228

Group type: EXPERIMENTAL
Intervention: P+P intervention (patients and their intimate partners)
Number of subjects: 301

Group type: COMPARATOR
Intervention: P-only intervention (patients only)
Number of subjects: 301
Study: 33382828

Group type: EXPERIMENTAL
Intervention: Sickle Cell Trait (SCT)
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Homozygous α-thalassemia and hemizygous G6PD deficiency
Number of subjects: 431

Group type: COMPARATOR
Intervention: HbA1c
Number of subjects: 431
Study: 35963082

Group type: EXPERIMENTAL
Intervention: Xylocaine 10% pump spray
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal saline 0.9%
Number of subjects: 80
Study: 33774172

Group type: EXPERIMENTAL
Intervention: Physiotherapy (group 1)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Acromioplasty and physiotherapy (group 2)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Rotator cuff repair, acromioplasty, and physiotherapy (group 3)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Trial population (all groups combined)
Number of subjects: 150
Study: 32841543

Group type: EXPERIMENTAL
Intervention: Involved-field irradiation (IFI)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Elective nodal irradiation (ENI)
Number of subjects: 228
Study: 34582077

Group type: EXPERIMENTAL
Intervention: Vocational rehabilitation group intervention alongside individualised vocational rehabilitation (IVR) for 8 weeks
Number of subjects: 49

Group type: COMPARATOR
Intervention: Individualised vocational rehabilitation (IVR) only for 8 weeks
Number of subjects: 49
Study: 35005871

Group type: EXPERIMENTAL
Intervention: Novel hyaluronic acid injectable gel with 0.3% lidocaine (test device)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Commercially available injectable hyaluronic acid gel with 0.3% lidocaine (comparator)
Number of subjects: 158
Study: 32468413

Group type: EXPERIMENTAL
Intervention: Antiviral therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Routine care practices
Number of subjects: 0
Study: 33169863

Group type: EXPERIMENTAL
Intervention: Single bolus of vitamin D(3) (300,000 IU)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Daily 1,000 IU vitamin D(3)
Number of subjects: 38
Study: 32540319

Group type: EXPERIMENTAL
Intervention: Survey on dentists' beliefs and behaviors concerning antibiotic prophylaxis (AP)
Number of subjects: 3584
Study: 33470637

Group type: EXPERIMENTAL
Intervention: Interleukin-1 receptor antagonism as adjunct therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 35920045

Group type: EXPERIMENTAL
Intervention: Goat milk yogurt (GMY)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: GMY & C (308.64g GMY & 18.88g C)
Number of subjects: 12

Group type: COMPARATOR
Intervention: D-glucose (25g)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Corinthian raisins (37.76g)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sultana raisins (37.48g)
Number of subjects: 12
Study: 33549444

Group type: EXPERIMENTAL
Intervention: Economic Hardship Score (EHS; range 0–14) based on three domains: change in employment status, financial hardship, and financial hardship for health expenditures.
Number of subjects: 3646
Study: 34090451

Group type: EXPERIMENTAL
Intervention: Betaine group (BG, n=14, 2g/day)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo group (PG, n=15)
Number of subjects: 29
Study: 35508529

Group type: EXPERIMENTAL
Intervention: Probiotics plus dietary fiber
Number of subjects: 0

Group type: COMPARATOR
Intervention: Probiotics alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dietary fiber only
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32898839

Group type: EXPERIMENTAL
Intervention: Aggregate-level screening for ACEs
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: PEARLS scores (general health assessment)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: PEARLS scores (Global Executive Functioning assessment)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: PEARLS scores (stomachaches)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: PEARLS scores (asthma)
Number of subjects: 367
Study: 36060517

Group type: EXPERIMENTAL
Intervention: TP (docetaxel 75 mg/m², cisplatin 75 mg/m²)
Number of subjects: 361

Group type: COMPARATOR
Intervention: TPF (docetaxel 60 mg/m², cisplatin 60 mg/m², 5-fluorouracil 600 mg/m²)
Number of subjects: 361
Study: 33832384

Group type: EXPERIMENTAL
Intervention: Wellness intervention (yoga, mindfulness, walking)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 33407804

Group type: EXPERIMENTAL
Intervention: REGAIN programme: an eight week, online, home‐based, supervised, group rehabilitation programme.
Number of subjects: 535

Group type: COMPARATOR
Intervention: Best-practice usual care: A thirty‐minute, online, one‐to‐one consultation with a REGAIN practitioner.
Number of subjects: 535
Study: 33878462

Group type: EXPERIMENTAL
Intervention: Diphenhydramine Compound (Diphenhydramine + Ammonium Chloride) plus standard of care
Number of subjects: 120

Group type: COMPARATOR
Intervention: Diphenhydramine alone and standard of care
Number of subjects: 120